Latest news
United Therapeutics(UTHR.US) Officer Sells US$4.99 Million in Common Stock - MoomooMoomoo · Fri, 07 Aug 2026 22:09:22 GMTUnited Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock TitanStock Titan · Fri, 07 Aug 2026 20:32:02 GMTStronger EPS, Ralinepag Progress, and Buybacks Might Change The Case For Investing In United Therapeutics (UTHR) - simplywall.stsimplywall.st · Fri, 07 Aug 2026 11:53:06 GMTRBC Capital Sticks to Their Buy Rating for United Therapeutics (UTHR) - theglobeandmail.comtheglobeandmail.com · Fri, 07 Aug 2026 11:14:00 GMTUnited Therapeutics(UTHR.US) Officer Sells US$4.29 Million in Common Stock - MoomooMoomoo · Fri, 07 Aug 2026 03:37:11 GMTUnited Therapeutics(UTHR.US) Officer Sells US$4.93 Million in Common Stock - MoomooMoomoo · Fri, 07 Aug 2026 03:26:12 GMTUnited Therapeutics (UTHR) counsel exercises options, sells 8,300 shares - Stock TitanStock Titan · Thu, 06 Aug 2026 23:01:06 GMTMorgan Stanley Adjusts PT on United Therapeutics to $515 From $516, Maintains Equalweight Rating - MoomooMoomoo · Thu, 06 Aug 2026 22:25:51 GMT